NormOxys Secures $600,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    16 Laurel Ave. Wellesley, MA 02481
  • Company Description
    NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed in a broad range of clinical indications where therapeutic benefit can be obtained through an increased, regulated delivery of oxygen to hypoxic tissues, such as cancer, cardiovascular diseases, anemia, stroke and diabetic retinopathy.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Secured convertible promissory notes. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy